Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Imiquimod shows promise as a non-invasive treatment for certain HPV-related lesions, but more research is needed to optimize its use.

Low-dose Ritlecitinib may help children with stubborn Alopecia Areata.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

Tislelizumab can cause cutaneous lupus erythematosus.

Flutamide worked better than finasteride for reducing excessive hair growth in women, but had more side effects.

Bicalutamide, a drug with a good safety profile, is a promising new treatment for female pattern hair loss.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

Flutamide combined with a low-dose birth control pill effectively reduces excessive hair growth in women with polycystic ovarian disease.

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

Rituximab may cause skin issues, but baricitinib can help improve them.

Ritlecitinib is effective for treating alopecia areata, showing significant hair regrowth with mild side effects.

Ritlecitinib helps adolescents with severe alopecia areata regrow scalp hair and normalize body hair and nails.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

Deuruxolitinib significantly helps regrow scalp hair in adults with moderate to severe alopecia areata.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

A woman with severe angioedema improved significantly after treatment with rituximab.

Flutamide reduces hair growth better but has more side effects.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

Deuruxolitinib effectively improves hair regrowth in alopecia areata but requires monitoring for side effects.

The synthetic retinoid EC23 thickens skin and promotes hair growth more effectively and with a lower dose than natural retinoids.

Upadacitinib improved multiple immune-related conditions in one patient.

Ritlecitinib effectively regrows eyebrow and eyelash hair in alopecia areata, with 50 mg being the best dose.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Liraglutide with metformin reduces body fat and improves blood sugar control better than metformin and inositol in women with prediabetes.

Bicalutamide may be a promising alternative treatment for female pattern hair loss.

Immunotherapy with pembrolizumab significantly reduced cancer in a young woman with adrenocortical carcinoma.